Goserelin EP Impurity J is a minor related variant formed during goserelin production. Sequence or oxidation differences produce characteristic shifts in retention time and structural stability. Researchers use it to validate impurity profiling techniques. Applications include QC evaluation, degradation-pathway analysis, and synthetic-route optimization.
CAT No: Z10-101-237
Synonyms/Alias:(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[(2S)-2-[(carbamoylamino)carbamoyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide; endo-8a-L-proline-goserelin
Goserelin EP Impurity J is a specialized carbohydrate compound recognized for its significance in the analytical and research sectors, particularly in the context of peptide-related studies. As a structurally defined impurity associated with the synthetic peptide goserelin, this compound serves as an essential reference standard in laboratories focused on pharmaceutical development and quality control. Its unique molecular configuration allows researchers to distinguish and quantify trace levels of impurities, thereby supporting detailed impurity profiling. The compound's stability and well-characterized properties make it highly valuable for method validation and calibration purposes, enabling consistent and reproducible analytical results across a variety of experimental setups.
Pharmaceutical Analysis: Goserelin EP Impurity J plays a pivotal role in pharmaceutical analysis, where it is utilized as a reference material for the identification and quantification of impurities in goserelin formulations. Through high-performance liquid chromatography (HPLC) or mass spectrometry, analysts can employ this impurity to verify the specificity and sensitivity of their detection methods. Its presence allows analytical chemists to optimize separation techniques and confirm the accuracy of impurity profiles, ensuring robust quality assurance processes during drug development and manufacturing.
Method Validation: In method validation studies, Goserelin EP Impurity J is frequently used to establish the linearity, precision, and accuracy of analytical procedures designed for peptide drugs. By incorporating known quantities of this impurity into test samples, researchers can assess the recovery rates and detection limits of their methods. This process is critical for demonstrating that analytical techniques are reliable and capable of detecting even minimal levels of structurally similar byproducts, which supports regulatory submissions and internal quality standards.
Peptide Synthesis Research: Within peptide synthesis laboratories, the presence of Goserelin EP Impurity J offers insights into the synthetic pathways and degradation mechanisms of goserelin. Researchers can monitor the formation of this impurity during various stages of peptide assembly, purification, and storage. Such studies help elucidate the factors that contribute to impurity generation, guiding the optimization of synthetic protocols and purification strategies to minimize unwanted byproducts in the final product.
Stability Testing: The use of Goserelin EP Impurity J is instrumental in stability testing programs, where it serves as a benchmark for detecting and quantifying degradation products over time. By spiking stability samples with this impurity, scientists can evaluate the performance of analytical methods under stress conditions such as heat, light, or humidity. These experiments provide valuable data on impurity behavior, enabling more accurate shelf-life predictions and informing best practices for storage and handling of peptide therapeutics.
Impurity Profiling in Research and Development: In research and development settings, Goserelin EP Impurity J aids in comprehensive impurity profiling of experimental goserelin batches. Its inclusion in analytical workflows allows scientists to map the impurity landscape with high precision, facilitating the identification of potential process-related or degradation-related byproducts. This detailed profiling is crucial for troubleshooting manufacturing issues, refining synthetic routes, and ensuring the overall integrity of peptide-based research materials. Through these diverse applications, Goserelin EP Impurity J continues to be an indispensable tool for advancing analytical science and supporting the development of high-quality peptide therapeutics.
3. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
4. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
5. Emu oil in combination with other active ingredients for treating skin imperfections
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More